Sequoia Financial Advisors’s Rein Therapeutics RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$189K Sell
234,668
-15,332
-6% -$12.6K ﹤0.01% 1659
2026
Q2
$260K Buy
+250,000
New +$302K ﹤0.01% 1783

Other funds holding RNTX

Sequoia Financial Advisors's RNTX Position: Q3 2026 in Review

Sequoia Financial Advisors reduced its Rein Therapeutics (RNTX) stake by 6.1% in Q3 2026, selling an estimated $12.6K and leaving 234,668 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Sequoia Financial Advisors first reported a position in RNTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $260K in Q2 2026. 64 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.

  • Sequoia Financial Advisors held 234,668 shares of Rein Therapeutics worth $189K as of Q3 2026.
  • Sequoia Financial Advisors sold 15,332 Rein Therapeutics shares in Q3 2026, an estimated $12.6K.
  • Rein Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q3 2026, its #1659 holding.
  • Sequoia Financial Advisors first reported a position in Rein Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Sequoia Financial Advisors's Rein Therapeutics position peaked at $260K in Q2 2026.
  • 64 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.

Based on Sequoia Financial Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.